The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum ; volume:22 ; number:1 ; day:14 ; month:5 ; year:2024 ; pages:1-15 ; date:12.2024
Cell communication and signaling ; 22, Heft 1 (14.5.2024), 1-15, 12.2024
- Creator
-
Guo, Jing
Li, Liping
Cai, Yue
Kang, Yongbo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-024-01611-z
- URN
-
urn:nbn:de:101:1-2408060858179.923976008254
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guo, Jing
- Li, Liping
- Cai, Yue
- Kang, Yongbo
- SpringerLink (Online service)
Other Objects (12)
Correction: The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum
Prodrug Integrated Envelope on Probiotics to Enhance Target Therapy for Ulcerative Colitis
Ulcerative colitis: molecular insights and intervention therapy
Severe de novo Ulcerative Colitis following Ixekizumab Therapy
The impacts of probiotics in eradication therapy of Helicobacter pylori
Topical Probiotics in Dermatological Therapy and Skincare: A Concise Review
Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series
Adjunct therapy with probiotics for chronic urticaria in children: randomised placebo-controlled trial
Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis
Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
Nothing ventured, nothing gained
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Correction: The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum
Prodrug Integrated Envelope on Probiotics to Enhance Target Therapy for Ulcerative Colitis
Ulcerative colitis: molecular insights and intervention therapy
Severe de novo Ulcerative Colitis following Ixekizumab Therapy
The impacts of probiotics in eradication therapy of Helicobacter pylori
Topical Probiotics in Dermatological Therapy and Skincare: A Concise Review
Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series
Adjunct therapy with probiotics for chronic urticaria in children: randomised placebo-controlled trial
Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis
Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
Nothing ventured, nothing gained
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Correction: The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum
Prodrug Integrated Envelope on Probiotics to Enhance Target Therapy for Ulcerative Colitis
Ulcerative colitis: molecular insights and intervention therapy
Severe de novo Ulcerative Colitis following Ixekizumab Therapy
The impacts of probiotics in eradication therapy of Helicobacter pylori
Topical Probiotics in Dermatological Therapy and Skincare: A Concise Review
Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series
Adjunct therapy with probiotics for chronic urticaria in children: randomised placebo-controlled trial
Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis
Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
Nothing ventured, nothing gained